Abstract

Stakeholder consultation is an integral part of the NICE clinical guideline development process. Comments received are a vital part of the robust quality-assurance and peer-review processes. The NICE guideline for Atrial Fibrillation underwent consultation (September–November 2020) giving stakeholders such as clinical and patient experts the opportunity to comment on a draft recommendation for the direct-acting oral anticoagulants (DOACs) for the management of patients with atrial fibrillation (AF).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call